Cannabis Regulations — 1
hich the sale of cannabis is authorized in accordance with section C.05.006 of those Regulations. This definition does not include research (a) related to the diagnosis, treatment, mitigation or prevention of a disease, disorder or abnormal physical state, or its symptoms, or the restoration or correction of organic functions, in human beings or animals; (b) involving the distribution of cannabis that is (i) represented for use in the diagnosis, treatment, mitigation or prevention of a disease, disorder or abnormal physical state, or its symptoms, or the restoration or correction of organic functions, in human beings or animals, (ii) manufactured or sold by any person other than a licence holder referred to in paragraph 2(a) of the Cannabis Exemption (Food and Drugs Act) Regulations for use in the diagnosis, treatment, mitigation or prevention of a disease, disorder or abnormal physical state, or its symptoms, or in the restoration or correction of organic functions, in human beings or animals, (iii) referred to in any of paragraphs 1(b) to (d) of the Cannabis Exemption (Food and Drugs Act) Regulations , or (iv) referred to in paragraph 1(f) of the Cannabis Exemption (Food and Drugs Act) Regulations in respect of an experimental study as defined in subsection C.08.013(2) of the Food and Drug Regulations ; (c) involving the distribution of cannabis that contains any substance that is referred to in column 1 of Schedule 5 to the Act and that (i) in the case of cannabis that is a cannabis product or that is contained in a cannabis accessory that is a cannabis product, does not meet the requirements set out in subsection 101.3(5.1) or (6) or section 101.31, 102.2 or 102.3, and (ii) in the case of any other cannabis, would not meet the requirements set out in subsection 101.3(5.1) or (6) or section 101.31, 102.2 or 102.3 if it were a cannabis product or if it were contained in a cannabis accessory that is a cannabis product; or (d) involving the participation of, or relating to, a young person. ( recherche non thérapeutique sur le cannabis ) operations area means, in respect of a site set out in a licence, an area of the site — other than a storage area — where cannabis is present as a result of any activities conducted under a licence. It includes a grow area. ( zone d’exploitation ) pest control product has the same meaning as in subsection 2(1) of the Pest Control Products Act . ( produit antiparasitaire ) pharmacist means an individual who is entitled under the laws of a province to practise pharmacy and who is practising pharmacy in that province. ( pharmacien ) point means the unit of measurement for type size that is known as a PostScript point and is equal to 0.3527777778 mm. ( point ) potential to convert CBDA into CBD means the maximum amount of CBD that would be obtained if CBDA was converted into CBD with no further degradation of CBD. ( potentiel de transformation de l’ACBD en CBD ) potential to convert THCA into THC means the maximum amount of THC that would be obtained if THCA was converted into THC with no further degradation of THC. ( potentiel de transformation de l’ATHC en THC ) poultry product has the same meaning as in subsection B.01.001(1) of the Food and Drug Regulations . ( produit de volaille ) prescription has the same meaning as in subsection C.01.001(1) of the Food and Drug Regulations . ( ordonnance ) prescription drug means a drug (a) that contains cannabis; (b) that is a prescription drug , as defined in section A.01.010 of the Food and Drug Regulations ; and (c) for which a drug identification number has been assigned under subsection C.01.014.2(1) of the Food and Drug Regulations . ( drogue sur ordonnance ) proper name has the same meaning as in subsection C.01.001(1) of the Food and Drug Regulations . ( nom propre ) reference standard means a standardized form of cannabis that is intended to be used as a measurement base when testing a substance to confirm its identity, concentration, quality or p